![Kevin Fitzgerald](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin Fitzgerald
No más puestos en curso
Origen de la red de primer grado Kevin Fitzgerald.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
![]() F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria.
2
| Subsidiary | Medical Specialties | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Kevin Fitzgerald a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Antisoma Research Ltd. | General Counsel | ||
RENEURON GROUP PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Bath | College/University | Corporate Officer/Principal | |
BIOTAGE AB | Medical Specialties | Chief Tech/Sci/R&D Officer | |
University of Oxford | College/University | Doctorate Degree | |
University of Leicester | College/University | Undergraduate Degree | |
MIP Technologies AB
![]() MIP Technologies AB Miscellaneous Commercial ServicesCommercial Services MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides. | Miscellaneous Commercial Services | Chief Executive Officer | |
SpinChem AB
![]() SpinChem AB Industrial ConglomeratesProducer Manufacturing SpinChem AB engages in the development, manufacture, and sale of products for chemical synthesis. It offers SpinChem, an innovative concept for mass transfer enhancement in reactions involving solid phase reagents, encompassing several different ways of using the stirring element itself to establish a forced flow through a heterogeneous reactant or catalyst bed, which is located inside the stirrer body. The company was founded by Fredrik Almqvist and Kjell Robert Öberg in 2007 and is headquartered in Umea, Sweden. | Industrial Conglomerates | Chairman | |
Westerly Projects Ltd. | Director/Board Member |
Estadísticas
Internacional
Reino Unido | 10 |
Suecia | 4 |
Estados Unidos | 3 |
Sectorial
Health Technology | 7 |
Consumer Services | 4 |
Commercial Services | 2 |
Producer Manufacturing | 2 |
Operativa
Corporate Officer/Principal | 5 |
Director/Board Member | 3 |
Chairman | 2 |
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Las relaciones más conectadas
Insiders | |
---|---|
Anthony Robert Rees | 10 |
Sharon Grimster | 6 |
- Bolsa de valores
- Insiders
- Kevin Fitzgerald
- Conexiones Empresas